Mast Therapeutics Inc., of San Diego, said it closed its underwritten public offering of 29.09 million units at $0.275 per unit. Each unit consisted of one share of the company's common stock and one warrant to purchase one share of the company's common stock at an exercise price of $0.42 per share.